Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Valleron, AJ; Boelle, PY; Will, R; Cesbron, JY
   Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom
   SCIENCE
   
   A.J. Valleron et al., "Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom", SCIENCE, 294(5547), 2001, pp. 1726-1728
2. Valleron, AJ
   Evidence and causality assessment in environmental epidemiology: methodological aspects.
   COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
   
   A.J. Valleron, "Evidence and causality assessment in environmental epidemiology: methodological aspects.", CR AC S III, 323(7), 2000, pp. 617-628
3. Valleron, AJ
   Roles of mathematical modelling in epidemiology
   COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
   
   A.J. Valleron, "Roles of mathematical modelling in epidemiology", CR AC S III, 323(5), 2000, pp. 429-433
4. Deuffic, S; Poynard, T; Valleron, AJ
   Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe
   JOURNAL OF VIRAL HEPATITIS
   
   S. Deuffic et al., "Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe", J VIRAL HEP, 6(5), 1999, pp. 411-413
5. Carrat, F; Tachet, A; Rouzioux, C; Housset, B; Valleron, AJ
   Evaluation of clinical case definitions of influenza: Detailed investigation of patients during the 1995-1996 epidemic in France
   CLINICAL INFECTIOUS DISEASES
   
   F. Carrat et al., "Evaluation of clinical case definitions of influenza: Detailed investigation of patients during the 1995-1996 epidemic in France", CLIN INF D, 28(2), 1999, pp. 283-290
6. Cohen, CH; Valleron, AJ
   When did bovine spongiform encephalopathy (BSE) start? Implications on theprediction of a new variant of Creutzfeldt-Jakob disease (nvCJD) epidemic
   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
   
   C.H. Cohen e A.J. Valleron, "When did bovine spongiform encephalopathy (BSE) start? Implications on theprediction of a new variant of Creutzfeldt-Jakob disease (nvCJD) epidemic", INT J EPID, 28(3), 1999, pp. 526-531
7. Deuffic, S; Buffat, L; Poynard, T; Valleron, AJ
   Modeling the hepatitis C virus epidemic in France
   HEPATOLOGY
   
   S. Deuffic et al., "Modeling the hepatitis C virus epidemic in France", HEPATOLOGY, 29(5), 1999, pp. 1596-1601
8. Yazdanpanah, Y; Boelle, PY; Carrat, F; Guiguet, M; Abiteboul, D; Valleron, AJ
   Risk of hepatitis C virus transmission to surgeons and nurses from infected patients: model-based estimates in France
   JOURNAL OF HEPATOLOGY
   
   Y. Yazdanpanah et al., "Risk of hepatitis C virus transmission to surgeons and nurses from infected patients: model-based estimates in France", J HEPATOL, 30(5), 1999, pp. 765-769
9. Chauvin, P; Valleron, AJ
   Persistence of susceptibility to measles in France despite routine immunization: A cohort analysis
   AMERICAN JOURNAL OF PUBLIC HEALTH
   
   P. Chauvin e A.J. Valleron, "Persistence of susceptibility to measles in France despite routine immunization: A cohort analysis", AM J PUB HE, 89(1), 1999, pp. 79-81
10. Cohen, CH; Cesbron, JY; Valleron, AJ
    Cost-effectiveness of bovine spongiform encephalopathy screening
    VETERINARY RECORD
    
    C.H. Cohen et al., "Cost-effectiveness of bovine spongiform encephalopathy screening", VET REC, 144(25), 1999, pp. 703-706
11. ILG AGS; BIGNON J; VALLERON AJ
    ESTIMATION OF THE PAST AND FUTURE BURDEN OF MORTALITY FROM MESOTHELIOMA IN FRANCE
    Occupational and environmental medicine
    
    A.G.S. Ilg et al., "ESTIMATION OF THE PAST AND FUTURE BURDEN OF MORTALITY FROM MESOTHELIOMA IN FRANCE", Occupational and environmental medicine, 55(11), 1998, pp. 760-765
12. YAZDANPANAH Y; BOELLE PY; CARRAT F; GUIGUET M; VALLERON AJ
    RISK OF HEPATITIS-C VIRUS (HCV) TRANSMISSION TO A SURGEON FROM AN INFECTED PATIENT - ESTIMATES IN FRANCE BASED ON A MODEL
    Infection control and hospital epidemiology
    
    Y. Yazdanpanah et al., "RISK OF HEPATITIS-C VIRUS (HCV) TRANSMISSION TO A SURGEON FROM AN INFECTED PATIENT - ESTIMATES IN FRANCE BASED ON A MODEL", Infection control and hospital epidemiology, 19(8), 1998, pp. 604-604
13. KARMOCHKINE M; CARRAT F; VALLERON AJ; RAGUIN G
    MODES OF HEPATITIS-C VIRUS TRANSMISSION
    La Presse medicale
    
    M. Karmochkine et al., "MODES OF HEPATITIS-C VIRUS TRANSMISSION", La Presse medicale, 27(18), 1998, pp. 871-876
14. Valleron, AJ
    Claude Chastang, professor of biostatistics - Necrology
    PRESSE MEDICALE
    
    A.J. Valleron, "Claude Chastang, professor of biostatistics - Necrology", PRESSE MED, 27(36), 1998, pp. 1856-1856
15. CARRAT F; GUEZELOT M; CHAUVIN P; IMBERT JC; VALLERON AJ; LEBAS J
    ACCESS TO HEALTH-INSURANCE COVERAGE OF UNINSURED PATIENTS ATTENDING AN OUTPATIENT-CLINIC - A HISTORICAL PROSPECTIVE-STUDY IN PARIS, FRANCE
    Revue d'epidemiologie et de sante publique
    
    F. Carrat et al., "ACCESS TO HEALTH-INSURANCE COVERAGE OF UNINSURED PATIENTS ATTENDING AN OUTPATIENT-CLINIC - A HISTORICAL PROSPECTIVE-STUDY IN PARIS, FRANCE", Revue d'epidemiologie et de sante publique, 46(5), 1998, pp. 361-370
16. CARRAT F; TACHET A; ROUZIOUX C; HOUSSET B; VALLERON AJ
    FIELD INVESTIGATION OF INFLUENZA VACCINE EFFECTIVENESS ON MORBIDITY
    Vaccine
    
    F. Carrat et al., "FIELD INVESTIGATION OF INFLUENZA VACCINE EFFECTIVENESS ON MORBIDITY", Vaccine, 16(9-10), 1998, pp. 893-898
17. CHAUVIN P; VALLERON AJ
    PARTICIPATION OF FRENCH GENERAL-PRACTITIONERS IN PUBLIC-HEALTH SURVEILLANCE - A MULTIDISCIPLINARY APPROACH
    Journal of epidemiology and community health
    
    P. Chauvin e A.J. Valleron, "PARTICIPATION OF FRENCH GENERAL-PRACTITIONERS IN PUBLIC-HEALTH SURVEILLANCE - A MULTIDISCIPLINARY APPROACH", Journal of epidemiology and community health, 52, 1998, pp. 2-8
18. CARRAT F; FLAHAULT A; BOUSSARD E; FARRAN N; DANGOUMAU L; VALLERON AJ
    SURVEILLANCE OF INFLUENZA-LIKE ILLNESS IN FRANCE - THE EXAMPLE OF THE1995 1996 EPIDEMIC/
    Journal of epidemiology and community health
    
    F. Carrat et al., "SURVEILLANCE OF INFLUENZA-LIKE ILLNESS IN FRANCE - THE EXAMPLE OF THE1995 1996 EPIDEMIC/", Journal of epidemiology and community health, 52, 1998, pp. 32-38
19. DEUFFIC S; POYNARD T; BUFFAT L; VALLERON AJ
    TRENDS IN PRIMARY LIVER-CANCER
    Lancet
    
    S. Deuffic et al., "TRENDS IN PRIMARY LIVER-CANCER", Lancet, 351(9097), 1998, pp. 214-215
20. FLAHAULT A; DIASFERRAO V; CHABERTY P; ESTEVES K; VALLERON AJ; LAVANCHY D
    FLUNET AS A TOOL FOR GLOBAL MONITORING OF INFLUENZA ON THE WEB
    JAMA, the journal of the American Medical Association
    
    A. Flahault et al., "FLUNET AS A TOOL FOR GLOBAL MONITORING OF INFLUENZA ON THE WEB", JAMA, the journal of the American Medical Association, 280(15), 1998, pp. 1330-1332
21. BOELLE PY; VIBERT JF; GARNERIN P; VALLERON AJ
    SHARE - A TOOL TO ANALYZE AND ASSESS STRATEGIES IN HEALTH-CARE ORGANIZATION MANAGEMENT
    Computers and biomedical research
    
    P.Y. Boelle et al., "SHARE - A TOOL TO ANALYZE AND ASSESS STRATEGIES IN HEALTH-CARE ORGANIZATION MANAGEMENT", Computers and biomedical research, 31(1), 1998, pp. 47-58
22. CARRAT F; TACHET A; HOUSSET B; VALLERON AJ; ROUZIOUX C
    INFLUENZA AND INFLUENZA-LIKE ILLNESS IN GENERAL-PRACTICE - DRAWING LESSONS FOR SURVEILLANCE FROM A PILOT-STUDY IN PARIS, PRANCE
    British journal of general practice
    
    F. Carrat et al., "INFLUENZA AND INFLUENZA-LIKE ILLNESS IN GENERAL-PRACTICE - DRAWING LESSONS FOR SURVEILLANCE FROM A PILOT-STUDY IN PARIS, PRANCE", British journal of general practice, 47(417), 1997, pp. 217-220
23. FLAHAULT A; BOUSSARD E; VIBERT JF; VALLERON AJ
    SENTIWEB REMAINS EFFICIENT TOOL FOR NATIONWIDE SURVEILLANCE OF DISEASE
    BMJ. British medical journal
    
    A. Flahault et al., "SENTIWEB REMAINS EFFICIENT TOOL FOR NATIONWIDE SURVEILLANCE OF DISEASE", BMJ. British medical journal, 314(7091), 1997, pp. 1418-1418
24. CHAUVIN P; MORTIER E; CARRAT F; IMBERT JC; VALLERON AJ; LEBAS J
    A NEW OUTPATIENT CARE FACILITY FOR HIV-INFECTED DESTITUTE POPULATIONSIN PARIS, FRANCE
    AIDS care
    
    P. Chauvin et al., "A NEW OUTPATIENT CARE FACILITY FOR HIV-INFECTED DESTITUTE POPULATIONSIN PARIS, FRANCE", AIDS care, 9(4), 1997, pp. 451-459
25. CHAUVIN P; VALLERON AJ
    MONITORING THE COMPLIANCE OF SENTINEL GENERAL-PRACTITIONERS IN PUBLIC-HEALTH SURVEILLANCE - WHICH GPS PERSEVERE
    International journal of epidemiology
    
    P. Chauvin e A.J. Valleron, "MONITORING THE COMPLIANCE OF SENTINEL GENERAL-PRACTITIONERS IN PUBLIC-HEALTH SURVEILLANCE - WHICH GPS PERSEVERE", International journal of epidemiology, 26(1), 1997, pp. 166-172
26. DEUFFIC S; BUFFAT L; POYNARD T; VALLERON AJ
    MODELING OF THE NATURAL-HISTORY OF HCV INFECTION PREDICTS A DRAMATIC INCREASE IN THE HCC MORTALITY BURDEN
    Hepatology
    
    S. Deuffic et al., "MODELING OF THE NATURAL-HISTORY OF HCV INFECTION PREDICTS A DRAMATIC INCREASE IN THE HCC MORTALITY BURDEN", Hepatology, 26(4), 1997, pp. 1482-1482
27. SEBILLE V; VALLERON AJ
    A COMPUTER-SIMULATION MODEL FOR THE SPREAD OF NOSOCOMIAL INFECTIONS CAUSED BY MULTIDRUG-RESISTANT PATHOGENS
    Computers and biomedical research
    
    V. Sebille e A.J. Valleron, "A COMPUTER-SIMULATION MODEL FOR THE SPREAD OF NOSOCOMIAL INFECTIONS CAUSED BY MULTIDRUG-RESISTANT PATHOGENS", Computers and biomedical research, 30(4), 1997, pp. 307-322
28. BOELLE PY; GARNERIN P; HERGON E; ROUGER P; VALLERON AJ
    QUALITY ASSURANCE AND PREVENTION OF IMMUN O-HEMOLYTIC INCIDENTS IN BLOOD-TRANSFUSION
    Transfusion clinique et biologique
    
    P.Y. Boelle et al., "QUALITY ASSURANCE AND PREVENTION OF IMMUN O-HEMOLYTIC INCIDENTS IN BLOOD-TRANSFUSION", Transfusion clinique et biologique, 3(1), 1996, pp. 27-34
29. BOUSSARD E; FLAHAULT A; VIBERT JF; VALLERON AJ
    SENTIWEB - FRENCH COMMUNICABLE DISEASE SURVEILLANCE ON THE WORLD-WIDE-WEB
    BMJ. British medical journal
    
    E. Boussard et al., "SENTIWEB - FRENCH COMMUNICABLE DISEASE SURVEILLANCE ON THE WORLD-WIDE-WEB", BMJ. British medical journal, 313(7069), 1996, pp. 1381-1382
30. CHAUVIN P; PETITPRETZ P; BRAI A; FOURNIER M; FLAHAULT A; NEUKIRCH F; VALLERON AJ
    MANAGEMENT OF EPISODES OF BRONCHIAL INFEC TIONS IN GENERAL MEDICINE
    Revue des maladies respiratoires
    
    P. Chauvin et al., "MANAGEMENT OF EPISODES OF BRONCHIAL INFEC TIONS IN GENERAL MEDICINE", Revue des maladies respiratoires, 13(4), 1996, pp. 397-404
31. CHAUVIN P; MORTIER E; VALLERON AJ; LEBAS J
    OUTPATIENTS CARE OF HIV-1-INFECTED DESTITUTE PEOPLE - A STUDY IN PARIS, FRANCE
    Lancet
    
    P. Chauvin et al., "OUTPATIENTS CARE OF HIV-1-INFECTED DESTITUTE PEOPLE - A STUDY IN PARIS, FRANCE", Lancet, 348(9025), 1996, pp. 480-480
32. LAZARD T; RETEL O; GUIDET B; MAURY E; VALLERON AJ; OFFENSTADT G
    AIDS IN A MEDICAL INTENSIVE-CARE UNIT - IMMEDIATE PROGNOSIS AND LONG-TERM SURVIVAL
    JAMA, the journal of the American Medical Association
    
    T. Lazard et al., "AIDS IN A MEDICAL INTENSIVE-CARE UNIT - IMMEDIATE PROGNOSIS AND LONG-TERM SURVIVAL", JAMA, the journal of the American Medical Association, 276(15), 1996, pp. 1240-1245
33. LEPONT F; COSTAGLIOLA D; ROUZIOUX C; VALLERON AJ
    TESTING FOR HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGEN - REPLY
    Transfusion
    
    F. Lepont et al., "TESTING FOR HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGEN - REPLY", Transfusion, 36(4), 1996, pp. 383-384
34. LEPONT F; COSTAGLIOLA D; VALLERON AJ; ROUZIOUX C
    HOW MUCH WOULD THE SAFETY OF BLOOD-TRANSFUSION BE IMPROVED BY INCLUDING P24 ANTIGEN IN THE BATTERY OF TESTS
    Transfusion
    
    F. Lepont et al., "HOW MUCH WOULD THE SAFETY OF BLOOD-TRANSFUSION BE IMPROVED BY INCLUDING P24 ANTIGEN IN THE BATTERY OF TESTS", Transfusion, 36(2), 1996, pp. 191-192
35. AYMARD M; AUTRET E; LEROY O; OLIVIER C; DANJOU C; PLETAN Y; ELHABIB R; REBIERE I; ESPIE J; ROUZIOUX JM; FRITZELL B; VALLERON AJ; HESSEL L
    EVALUATION METHODOLOGY OF VIRAL VACCINE
    Therapie
    
    M. Aymard et al., "EVALUATION METHODOLOGY OF VIRAL VACCINE", Therapie, 51(4), 1996, pp. 439-443
36. BOELLE PY; GARNERIN P; VALLERON AJ
    A SEQUENTIAL PROCEDURE TO TEST THE PROGRESSIVE DECREASE OF RARE ADVERSE EVENTS
    Computers in biology and medicine
    
    P.Y. Boelle et al., "A SEQUENTIAL PROCEDURE TO TEST THE PROGRESSIVE DECREASE OF RARE ADVERSE EVENTS", Computers in biology and medicine, 26(6), 1996, pp. 513-523
37. CHAUVIN P; VALLERON AJ
    ATTITUDE OF FRENCH GENERAL-PRACTITIONERS TO THE PUBLIC-HEALTH SURVEILLANCE OF COMMUNICABLE DISEASES
    International journal of epidemiology
    
    P. Chauvin e A.J. Valleron, "ATTITUDE OF FRENCH GENERAL-PRACTITIONERS TO THE PUBLIC-HEALTH SURVEILLANCE OF COMMUNICABLE DISEASES", International journal of epidemiology, 24(2), 1995, pp. 435-440
38. LEPONT F; COSTAGLIOLA D; MASSARI V; VALLERON AJ
    ESTIMATION OF THE SIZE OF THE HIV AIDS EPIDEMIC DUE TO BLOOD-TRANSFUSION IN FRANCE/
    International journal of epidemiology
    
    F. Lepont et al., "ESTIMATION OF THE SIZE OF THE HIV AIDS EPIDEMIC DUE TO BLOOD-TRANSFUSION IN FRANCE/", International journal of epidemiology, 24(2), 1995, pp. 441-445
39. CARRAT F; VALLERON AJ
    INFLUENZA MORTALITY AMONG THE ELDERLY IN FRANCE, 1980-90 - HOW MANY DEATHS MAY HAVE BEEN AVOIDED THROUGH VACCINATION
    Journal of epidemiology and community health
    
    F. Carrat e A.J. Valleron, "INFLUENZA MORTALITY AMONG THE ELDERLY IN FRANCE, 1980-90 - HOW MANY DEATHS MAY HAVE BEEN AVOIDED THROUGH VACCINATION", Journal of epidemiology and community health, 49(4), 1995, pp. 419-425
40. FLAHAULT A; GARNERIN P; CHAUVIN P; FARRAN N; SAIDI Y; DIAZ C; TOUBIANA L; DRUCKER J; VALLERON AJ
    SENTINELLE TRACES OF AN EPIDEMIC OF ACUTE GASTROENTERITIS IN FRANCE
    Lancet
    
    A. Flahault et al., "SENTINELLE TRACES OF AN EPIDEMIC OF ACUTE GASTROENTERITIS IN FRANCE", Lancet, 346(8968), 1995, pp. 162-163
41. LEPONT F; COSTAGLIOLA D; ROUZIOUX C; VALLERON AJ
    HOW MUCH WOULD THE SAFETY OF BLOOD-TRANSFUSION BE IMPROVED BY INCLUDING P24 ANTIGEN IN THE BATTERY OF TESTS
    Transfusion
    
    F. Lepont et al., "HOW MUCH WOULD THE SAFETY OF BLOOD-TRANSFUSION BE IMPROVED BY INCLUDING P24 ANTIGEN IN THE BATTERY OF TESTS", Transfusion, 35(7), 1995, pp. 542-547
42. TOUBIANA L; VIBERT JF; GARNERIN P; VALLERON AJ
    SITIE - A HEALTH-CARE WORKSTATION INTEGRATION ARCHITECTURE FOR EPIDEMIOLOGISTS
    Computers and biomedical research
    
    L. Toubiana et al., "SITIE - A HEALTH-CARE WORKSTATION INTEGRATION ARCHITECTURE FOR EPIDEMIOLOGISTS", Computers and biomedical research, 28(2), 1995, pp. 100-115
43. ROUZIOUX C; COSTAGLIOLA D; BURGARD M; BLANCHE S; MAYAUX MJ; GRISCELLI C; VALLERON AJ; ALLEMON MC; ARMENGAUD D; BABINET JM; BALDE P; BENFADEL F; BENSADOUN R; BERTEROTIERE D; BODDAERT M; BOMPARD Y; BOTTO C; BRUNNER AM; CACAULT JA; CARLUSMONCOMBLE C; CIRARUVIGNERON N; COHEN C; COLINGORKI AM; COURPOTIN C; CRUMIERE C; DALLOT MC; DANDINE M; DECREPY A; DEBONS M; DEBRE M; DENAVIT MF; DEVIDAS A; DUMONTEL M; FIRTION G; FLOCH C; FRANCOUAL C; FURIOLI J; GANTZER A; GRANIER F; GUILLOT F; HELLER B; HURAUXRENDU C; LABRUNE P; LACHASSINE E; LACROIX A; LANZA M; LAJALLE H; LELORIER B; LEBLANC A; LEBRUN F; LEJEUNE C; MAMOU J; MAY A; MAZI F; MEYER A; MOUCHNINO G; NARCY P; NOSEDA G; PASCAL C; PAUTARD B; ROBIN M; RONZIER M; ROPERT JL; ROUSSET MC; SAILLANT A; SCART G; SEAUME H; SEGUY D; TALON P; TARDIEU M; TERRIS J; VALDES L; VEBER F; VEDRENNE J; VIAL M; VINAS A; VINCENT N; WIPFF P
    ESTIMATED TIMING OF MOTHER-TO-CHILD HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TRANSMISSION BY USE OF A MARKOV MODEL
    American journal of epidemiology
    
    C. Rouzioux et al., "ESTIMATED TIMING OF MOTHER-TO-CHILD HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TRANSMISSION BY USE OF A MARKOV MODEL", American journal of epidemiology, 142(12), 1995, pp. 1330-1337
44. VALLERON AJ; CHAUVIN P; FLAHAULT A; VIBERT JF
    ALERT SYSTEMS - PAST, PRESENT AND FUTURE
    Transfusion clinique et biologique
    
    A.J. Valleron et al., "ALERT SYSTEMS - PAST, PRESENT AND FUTURE", Transfusion clinique et biologique, 1(6), 1994, pp. 443-454
45. ROUGER P; HERGON E; LEPENNEC PY; GARNERIN P; VALLERON AJ
    IMMUNOLOGICAL RISK IN BLOOD-TRANSFUSION A ND PUBLIC-HEALTH
    Transfusion clinique et biologique
    
    P. Rouger et al., "IMMUNOLOGICAL RISK IN BLOOD-TRANSFUSION A ND PUBLIC-HEALTH", Transfusion clinique et biologique, 1(2), 1994, pp. 141-153
46. RAFLA M; IBRAHIM AS; VALLERON AJ; MARY JY
    A CLASSIFICATION AFTER RADICAL CYSTECTOMY OF PATIENTS WITH BLADDER-CANCER ASSOCIATED WITH SCHISTOSOMIASIS
    European journal of cancer
    
    M. Rafla et al., "A CLASSIFICATION AFTER RADICAL CYSTECTOMY OF PATIENTS WITH BLADDER-CANCER ASSOCIATED WITH SCHISTOSOMIASIS", European journal of cancer, 30A(12), 1994, pp. 1751-1756
47. GUIGUET M; LEPONT F; RETEL O; VALLERON AJ
    CHANGES IN HIV RISK BEHAVIOR AMONG FRENCH HETEROSEXUALS - PATTERNS OFSEXUAL MONOGAMY AND CONDOM USE BETWEEN 1988 AND 1991
    Journal of acquired immune deficiency syndromes
    
    M. Guiguet et al., "CHANGES IN HIV RISK BEHAVIOR AMONG FRENCH HETEROSEXUALS - PATTERNS OFSEXUAL MONOGAMY AND CONDOM USE BETWEEN 1988 AND 1991", Journal of acquired immune deficiency syndromes, 7(12), 1994, pp. 1290-1291
48. CARRAT F; VALLERON AJ
    ANTI-FLU VACCINE - REVIEW OF THE LITERATU RE
    Revue des maladies respiratoires
    
    F. Carrat e A.J. Valleron, "ANTI-FLU VACCINE - REVIEW OF THE LITERATU RE", Revue des maladies respiratoires, 11(3), 1994, pp. 239-255
49. FLAHAULT A; DEGUEN S; VALLERON AJ
    A MATHEMATICAL-MODEL FOR THE EUROPEAN SPREAD OF INFLUENZA
    European journal of epidemiology
    
    A. Flahault et al., "A MATHEMATICAL-MODEL FOR THE EUROPEAN SPREAD OF INFLUENZA", European journal of epidemiology, 10(4), 1994, pp. 471-474
50. MASSARI V; COSTAGLIOLA D; VALLERON AJ
    ESTIMATION OF THE NUMBER OF HIV-SEROPOSITIVE PATIENTS KNOWN TO GENERAL-PRACTITIONERS IN FRANCE
    AIDS
    
    V. Massari et al., "ESTIMATION OF THE NUMBER OF HIV-SEROPOSITIVE PATIENTS KNOWN TO GENERAL-PRACTITIONERS IN FRANCE", AIDS, 8(8), 1994, pp. 1190-1191
51. RUDE N; COSTAGLIOLA D; VALLERON AJ
    PREVALENCE OF HIV-INFECTION IN FRANCE BEF ORE THE INTRODUCTION OF EARLY THERAPY - ESTIMATION BY BACKCALCULATION
    Revue d'epidemiologie et de sante publique
    
    N. Rude et al., "PREVALENCE OF HIV-INFECTION IN FRANCE BEF ORE THE INTRODUCTION OF EARLY THERAPY - ESTIMATION BY BACKCALCULATION", Revue d'epidemiologie et de sante publique, 41(6), 1993, pp. 437-446
52. RETEL O; COSTAGLIOLA D; VALLERON AJ
    ANALYSIS OF REPORTING DELAYS IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME CASES IN FRANCE
    Revue d'epidemiologie et de sante publique
    
    O. Retel et al., "ANALYSIS OF REPORTING DELAYS IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME CASES IN FRANCE", Revue d'epidemiologie et de sante publique, 41(6), 1993, pp. 447-453
53. MARYKRAUSE M; MARY JY; VALLERON AJ
    CONDITIONS OF VALIDATION AND USE OF THE SCREENING METHOD FOR VACCINE EFFICACY EVALUATION
    Revue d'epidemiologie et de sante publique
    
    M. Marykrause et al., "CONDITIONS OF VALIDATION AND USE OF THE SCREENING METHOD FOR VACCINE EFFICACY EVALUATION", Revue d'epidemiologie et de sante publique, 41(2), 1993, pp. 155-160
54. LEPONT F; VALLERON AJ; SPIRA A; BAJOS N; BEJIN A; BELTZER N; BOZON M; DUCOT B; DURANDEAU A; FERRAND A; GIAMI A; GILLOIRE A; GIRAUD M; LERIDON H; MESSIAH A; LUDWIG D; MOATTI JP; MOUNNIER L; OLOMUCKI H; POPLAVSKY J; RIANDEY B; SPENCER B; SZTALRYD JM; TOUZARD H
    POTENTIAL HIV EPIDEMIC ASSOCIATED WITH HETEROSEXUAL TRANSMISSION AMONG YOUTH IN FRANCE
    AIDS
    
    F. Lepont et al., "POTENTIAL HIV EPIDEMIC ASSOCIATED WITH HETEROSEXUAL TRANSMISSION AMONG YOUTH IN FRANCE", AIDS, 7(8), 1993, pp. 1134-1135
55. ROUZIOUX C; COSTAGLIOLA D; BURGARD M; BLANCHE S; MAYAUX MJ; GRISCELLI C; VALLERON AJ
    TIMING OF MOTHER-TO-CHILD HIV-1 TRANSMISSION DEPENDS ON MATERNAL STATUS
    AIDS
    
    C. Rouzioux et al., "TIMING OF MOTHER-TO-CHILD HIV-1 TRANSMISSION DEPENDS ON MATERNAL STATUS", AIDS, 7, 1993, pp. 190000049-190000052
56. RUDE N; COSTAGLIOLA D; VALLERON AJ
    CUMULATIVE INCIDENCE OF HIV-INFECTION AND AIDS CASE PREDICTION IN FRANCE
    Lancet
    
    N. Rude et al., "CUMULATIVE INCIDENCE OF HIV-INFECTION AND AIDS CASE PREDICTION IN FRANCE", Lancet, 342(8868), 1993, pp. 436-437